Comparison 6. Oxytocin + ergometrine versus ergot alkaloids‐‐subgroup analyses.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Blood loss 500 mL or more after delivery; active v. expectant management	1	354	Risk Ratio (M‐H, Fixed, 95% CI)	0.48 [0.15, 1.52]
1.1 Active management	1	354	Risk Ratio (M‐H, Fixed, 95% CI)	0.48 [0.15, 1.52]
1.2 Expectant management	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Blood loss 500 mL or more after delivery; IM v. IV oxytocin	3	1168	Risk Ratio (M‐H, Fixed, 95% CI)	0.44 [0.20, 0.94]
2.1 IM oxytocin	2	1161	Risk Ratio (M‐H, Fixed, 95% CI)	0.44 [0.20, 0.94]
2.2 IV oxytocin	1	7	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]